Skip to main content
editorial
. 2019 Sep 24;1(1):37–40. doi: 10.1016/j.jaccao.2019.08.010

Figure 1.

Figure 1

VEGFI Beneficial and Harmful Effects Leading to Improved Cancer Survival With Increased Cardiovascular Toxicities, Particularly Hypertension

Ideal management of patients should balance antiangiogenic and cardiovascular toxicities so that anticancer treatment is optimized in the absence of hypertension and cardiovascular disease. BP = blood pressure; CVD = cardiovascular disease; Rx = prescription; VEGFI = vascular endothelial growth factor inhibitor.